Skip to main content

Table 5 Test parameters for MPR cut-offs in detecting unfavourable viral outcomes

From: Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes

MPR category

Number of individuals in category

Number of individuals with unfavourable outcomes

Sensitivity % (95% CI)

Specificity % (95% CI)

PPV % (95% CI)

NPV % (95% CI)

ROCa area (95% CI)

< 0.80

97

21

65.6 (52.3–77.3)

12.2 (9.8–15.1)

6.8 (4.9–9.2)

78.4 (68.8–86.1)

0.39 (0.33–0.45)

< 0.90

137

24

60.7 (47.3–72.9)

18.2 (15.2–21.5)

6.8 (4.9–9.2)

82.5 (75.1–88.4)

0.39 (0.33–0.46)

< 0.95

197

31

49.2 (36.1–36.1)

26.7 (23.3–30.4)

6.2 (4.2–8.7)

84.3 (78.4–89.1)

0.38 (0.31–0.45)

< 1.00

346

44

27.9 (17.1–40.8)

48.6 (44.6–52.6)

5.1 (3.0–8.0)

87.3 (83.3–90.6)

0.38 (0.32–0.44)

< 1.05

510

52

14.8 (7.0–26.2)

73.8 (70.1–77.2)

5.2 (2.4–9.7)

89.8 (86.8–92.3)

0.44 (0.39–0.49)

  1. aThe average of sensitivity and specificity for the binary MPR cut-point being tested
  2. PPV Positive predictive value, NPV Negative predictive value, ROC receiver operating characteristic